AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33764278 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing approaches applied according to Meleis' Transition Theory
Number of subjects: 64
Study 33764278 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study 32334632 — intervention group
Group type: EXPERIMENTAL
Intervention: EM/AF + PF + PPC
Number of subjects: 0
Study 32334632 — intervention group
Group type: COMPARATOR
Intervention: EM/AF
Number of subjects: 0
Study 34920855 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncuffed 3.5 mm ID tracheal tube
Number of subjects: 30
Study 34920855 — intervention group
Group type: COMPARATOR
Intervention: Cuffed 3.0 mm ID tracheal tube
Number of subjects: 30
Study 33874974 — intervention group
Group type: EXPERIMENTAL
Intervention: VR based intervention along with standard treatment
Number of subjects: 60
Study 33874974 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment after surgery (control group)
Number of subjects: 60
Study 32571411 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) for 30 min at four acupoints, 4 times weekly for 12 weeks (total of 48 sessions)
Number of subjects: 60
Study 32571411 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupoint stimulation)
Number of subjects: 60
Study 35089798 — intervention group
Group type: EXPERIMENTAL
Intervention: Second tertile of European ancestry proportion
Number of subjects: 2466
Study 35089798 — intervention group
Group type: EXPERIMENTAL
Intervention: Third tertile of European ancestry proportion
Number of subjects: 2466
Study 35089798 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% point higher European ancestry
Number of subjects: 2466
Study 35089798 — intervention group
Group type: COMPARATOR
Intervention: Intensive versus standard blood pressure treatment
Number of subjects: 2466
Study 34131157 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (3‐min intervals at 40% and 80% of oxygen uptake reserve, n = 18)
Number of subjects: 54
Study 34131157 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 54
Study 34131157 — intervention group
Group type: EXPERIMENTAL
Intervention: MICT (sustained 60% of oxygen uptake reserve, n = 18)
Number of subjects: 54
Study 34131157 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTL, n = 18)
Number of subjects: 54
Study 36329080 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrients as nanoparticles (MN‐NPs) at a concentration of 40 mg/L
Number of subjects: 0
Study 36329080 — intervention group
Group type: COMPARATOR
Intervention: Micronutrients as nanoparticles (MN‐NPs) at concentrations of 0, 10, 20, 30 mg/L
Number of subjects: 0
Study 32250061 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mm subcrestally placed implants
Number of subjects: 32
Study 32250061 — intervention group
Group type: COMPARATOR
Intervention: Epicrestally placed implants with 2 mm healing abutment
Number of subjects: 32
Study 32250061 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcrestal implant placement
Number of subjects: 32
Study 32250061 — intervention group
Group type: COMPARATOR
Intervention: Soft tissue tenting
Number of subjects: 32
Study 35441463 — intervention group
Group type: EXPERIMENTAL
Intervention: VAIA (vincristine, ifosfamide, adriamycin, dactinomycin)
Number of subjects: 557
Study 35441463 — intervention group
Group type: COMPARATOR
Intervention: CEVAIE (carboplatin, epirubicin, vincristine, dactinomycin, ifosfamide, etoposide)
Number of subjects: 557
Study 34196588 — intervention group
Group type: EXPERIMENTAL
Intervention: Guava leaf extract-menthol toner
Number of subjects: 64
Study 34196588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 35379638 — intervention group
Group type: EXPERIMENTAL
Intervention: HUC-MSCs administered intravenously at a dose of 1×10^6 cells/kg with a total volume of 100 mL diluted with normal saline through 120 mL/hour intravenous central line infusion
Number of subjects: 40
Study 35379638 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline) administered through 120 mL/hour intravenous central line infusion at the same quantity (total volume of 100 mL)
Number of subjects: 40
Study 33942419 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centred self-management programme
Number of subjects: 70
Study 33942419 — intervention group
Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 70
Study 32530169 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal effort isokinetic knee exercises
Number of subjects: 200
Study 32530169 — intervention group
Group type: COMPARATOR
Intervention: Half effort isokinetic knee exercises
Number of subjects: 200
Study 37119361 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE-guided training (n = 10; 2 female)
Number of subjects: 30
Study 34441048 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactoferrin treatment for seven days
Number of subjects: 54
Study 34441048 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving approved Egyptian COVID-19 management protocol
Number of subjects: 54
Study 35429525 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz; n = 7)
Number of subjects: 14
Study 35429525 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz; n = 7)
Number of subjects: 14
Study 35429525 — intervention group
Group type: EXPERIMENTAL
Intervention: Both high-frequency and low-frequency rTMS
Number of subjects: 14
Study 33287418 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Join the Healthy Boat programme
Number of subjects: 231
Study 33287418 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 231
Study 35396667 — intervention group
Group type: EXPERIMENTAL
Intervention: favipiravir treatment (early treatment group on day 1)
Number of subjects: 32
Study 35396667 — intervention group
Group type: COMPARATOR
Intervention: favipiravir treatment (late treatment group on day 6)
Number of subjects: 32
Study 33674633 — intervention group
Group type: EXPERIMENTAL
Intervention: High circulating miR-21 levels
Number of subjects: 345
Study 33674633 — intervention group
Group type: EXPERIMENTAL
Intervention: High circulating miR-29a levels
Number of subjects: 345
Study 33674633 — intervention group
Group type: EXPERIMENTAL
Intervention: Low circulating miR-126 levels
Number of subjects: 345
Study 32445271 — intervention group
Group type: EXPERIMENTAL
Intervention: NexoBrid (NXB)
Number of subjects: 110
Study 32445271 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 110
Study 35177133 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-Modelling (VM)
Number of subjects: 24
Study 35177133 — intervention group
Group type: COMPARATOR
Intervention: Remote Telementoring (RTM)
Number of subjects: 24
Study 34537805 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother recording group
Number of subjects: 102
Study 34537805 — intervention group
Group type: EXPERIMENTAL
Intervention: Stranger recording group
Number of subjects: 102
Study 34537805 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 34761694 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary percutaneous peripheral nerve stimulation (PNS)
Number of subjects: 16
Study 34761694 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy alone
Number of subjects: 16
Study 33705917 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation
Number of subjects: 111
Study 32197594 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching puberty health concepts based on the health belief model (HBM) during eight 45-min sessions
Number of subjects: 60
Study 32197594 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecturing method (Control)
Number of subjects: 60
Study 34756997 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgluteal sciatic nerve block (SSNB)
Number of subjects: 60
Study 34756997 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (control)
Number of subjects: 60
Study 34333820 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg liquid (extracted from capsules)
Number of subjects: 1
Study 34333820 — intervention group
Group type: COMPARATOR
Intervention: Enzalutamide 40 mg liquid-filled soft-gelatin capsules (commercially available)
Number of subjects: 1
Study 34333820 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 1
Study 34872042 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice and blood flow restriction training (BFRT)
Number of subjects: 59
Study 34872042 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice and traditional high intensity training (HIT)
Number of subjects: 59
Study 34872042 — intervention group
Group type: COMPARATOR
Intervention: Advice only (control)
Number of subjects: 59
Study 34221381 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 15 mg
Number of subjects: 18
Study 34221381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34963639 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-Administered RZV and PCV13 (N=449)
Number of subjects: 912
Study 34963639 — intervention group
Group type: COMPARATOR
Intervention: Control group (sequential administration of PCV13 and RZV) (N=463)
Number of subjects: 912
Study 35714910 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Up!@Home intervention (12-week intervention with water filter and curriculum)
Number of subjects: 92
Study 35714910 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (water filter only)
Number of subjects: 92
Study 33487788 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Videos
Number of subjects: 93
Study 33487788 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing Gum
Number of subjects: 93
Study 33487788 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study 34653650 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing with Affirmative Care (MI-AC)
Number of subjects: 356
Study 34653650 — intervention group
Group type: COMPARATOR
Intervention: Motivational Interviewing (MI)
Number of subjects: 356
Study 34653650 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-AC
Number of subjects: 356
Study 34653650 — intervention group
Group type: COMPARATOR
Intervention: MI
Number of subjects: 356
Study 35235629 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineralized bone
Number of subjects: 50
Study 35235629 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bone
Number of subjects: 50
Study 32334955 — intervention group
Group type: EXPERIMENTAL
Intervention: Child restraint system education only
Number of subjects: 0
Study 32334955 — intervention group
Group type: EXPERIMENTAL
Intervention: Child restraint system education plus behavioral skills training
Number of subjects: 0
Study 32334955 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32334955 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 0
Study 32334955 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower parent's level of education
Number of subjects: 0
Study 32334955 — intervention group
Group type: EXPERIMENTAL
Intervention: Older child age (4 years)
Number of subjects: 0
Study 32334955 — intervention group
Group type: EXPERIMENTAL
Intervention: Older child age (5 years)
Number of subjects: 0
Study 32334955 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention component
Number of subjects: 0
Study 36109862 — intervention group
Group type: COMPARATOR
Intervention: Measurement awareness group (N=30)
Number of subjects: 90
Study 36109862 — intervention group
Group type: COMPARATOR
Intervention: Measurement awareness+track/record group (N=30)
Number of subjects: 90
Study 36109862 — intervention group
Group type: COMPARATOR
Intervention: Combined intervention groups (measurement awareness + measurement awareness+track/record)
Number of subjects: 90
Study 34319056 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Enough Sex (GES) model-based sexual counseling intervention, 4 sessions of 120-190 minutes each, with 2 and 3 months follow-up
Number of subjects: 100
Study 34319056 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 32767971 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage group
Number of subjects: 116
Study 35830361 — intervention group
Group type: EXPERIMENTAL
Intervention: LV unloading with the Impella CP followed by immediate reperfusion
Number of subjects: 50
Study 35830361 — intervention group
Group type: COMPARATOR
Intervention: Delayed reperfusion after 30 minutes of unloading
Number of subjects: 50
Study 33827392 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological therapy for depression
Number of subjects: 12
Study 33827392 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 12
Study 33827478 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education program and nurse-led telephone follow-up for 3 months
Number of subjects: 66
Study 32460801 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g HMB + 5 g creatine per day (HMB-Cr)
Number of subjects: 16
Study 32460801 — intervention group
Group type: COMPARATOR
Intervention: 5 g creatine + 5 g placebo per day (Cr)
Number of subjects: 16
Study 33934703 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed GnRH antagonist protocol (ganirelix 0.25 mg/d started on day 5)
Number of subjects: 201
Study 33934703 — intervention group
Group type: COMPARATOR
Intervention: Flexible GnRH antagonist protocol (started when LH > 10 IU/L, follicle > 12 mm, or serum E2 > 600 pg/ml)
Number of subjects: 201
Study 32141709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh inlay
Number of subjects: 55
Study 32141709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh kit
Number of subjects: 55
Study 32141709 — intervention group
Group type: COMPARATOR
Intervention: Standard (native tissue) repair
Number of subjects: 55
Study 35460359 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate (NO3‐) supplementation
Number of subjects: 16
Study 35460359 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16
Study 33059886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification (Lifestyle)
Number of subjects: 114
Study 33059886 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of intensive lifestyle modification and oral contraceptive pills (Combined)
Number of subjects: 114
Study 33059886 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive pills (OCP)
Number of subjects: 114
Study 35407483 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual Learning (PL) combined with patching
Number of subjects: 25
Study 35407483 — intervention group
Group type: COMPARATOR
Intervention: Patching only
Number of subjects: 25
Study 35238148 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ascorbic acid (AA) application
Number of subjects: 25
Study 35238148 — intervention group
Group type: COMPARATOR
Intervention: Placebo formulation
Number of subjects: 25
Study 33422621 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) using Samsung GearVR headset and AppliedVR software during the procedure
Number of subjects: 40
Study 33422621 — intervention group
Group type: COMPARATOR
Intervention: Control group (no VR)
Number of subjects: 40
Study 33422621 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 40
Study 32790792 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 9
Study 32790792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 32432491 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative opioid counseling
Number of subjects: 131
Study 32432491 — intervention group
Group type: COMPARATOR
Intervention: No counseling (Control)
Number of subjects: 131
Study 32990349 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotating antibiotics for 6 weeks in conjunction with darifenacin for 6 months
Number of subjects: 36
Study 32990349 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks in conjunction with darifenacin for 6 months
Number of subjects: 36
Study 33442930 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power short-duration pulmonary vein isolation using a specialized irrigated radiofrequency ablation catheter (QDOT) at 50 W with a target Ablation Index of 350 at posterior wall.
Number of subjects: 31
Study 32458352 — intervention group
Group type: EXPERIMENTAL
Intervention: Toggenburg bucks
Number of subjects: 0
Study 32458352 — intervention group
Group type: COMPARATOR
Intervention: Saanen bucks
Number of subjects: 0
Study 36216304 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol 0.25 μg once daily
Number of subjects: 127
Study 36149628 — intervention group
Group type: COMPARATOR
Intervention: Combined intracervical foley's catheter plus intravenous oxytocin infusion
Number of subjects: 158
Study 32560544 — intervention group
Group type: EXPERIMENTAL
Intervention: Active breaks (AB) intervention for 14 weeks
Number of subjects: 16
Study 32560544 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study 36070433 — intervention group
Group type: EXPERIMENTAL
Intervention: Maitake D-Fraction (4 capsules, 3 times a day, taken orally before meals)
Number of subjects: 141
Study 36070433 — intervention group
Group type: EXPERIMENTAL
Intervention: Maitake D-Fraction
Number of subjects: 141
Study 36070433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 33494479 — intervention group
Group type: COMPARATOR
Intervention: Abdominopelvic exercise program (AEP)
Number of subjects: 40
Study 33494479 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominopelvic exercise with postural instructions (AEPPI)
Number of subjects: 40
Study 35317128 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D convolutional neural network (3D‐CNN) algorithm for MRI images
Number of subjects: 96
Study 35317128 — intervention group
Group type: COMPARATOR
Intervention: Traditional CNN algorithm for MRI images
Number of subjects: 96
Study 32028288 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological reversal of neuromuscular blockade
Number of subjects: 923
Study 32028288 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous recovery of neuromuscular blockade
Number of subjects: 923
Study 34419597 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 2008
Study 32059695 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy for Children (KIDNET)
Number of subjects: 80
Study 32059695 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study 32675599 — intervention group
Group type: EXPERIMENTAL
Intervention: TiPEEK cage
Number of subjects: 149
Study 32675599 — intervention group
Group type: COMPARATOR
Intervention: PEEK cage
Number of subjects: 149
Study 34636474 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral injection with hyaluronic acid
Number of subjects: 20
Study 34636474 — intervention group
Group type: COMPARATOR
Intervention: Traditional percutaneous approach with hyaluronic acid
Number of subjects: 20
Study 33682145 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate infusion
Number of subjects: 16
Study 33682145 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 16
Study 34609048 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 mm annular zone (0.5 second on, 1 second off; 45 mW/cm2)
Number of subjects: 27
Study 34609048 — intervention group
Group type: COMPARATOR
Intervention: 4.0 mm annular zone (1 second on, 1 second off; 30 mW/cm2)
Number of subjects: 27
Study 32644127 — intervention group
Group type: EXPERIMENTAL
Intervention: KAF156 800 mg
Number of subjects: 14
Study 32644127 — intervention group
Group type: EXPERIMENTAL
Intervention: KAF156 50 mg
Number of subjects: 14
Study 32644127 — intervention group
Group type: EXPERIMENTAL
Intervention: KAF156 300 mg
Number of subjects: 14
Study 32644127 — intervention group
Group type: EXPERIMENTAL
Intervention: KAF156 100 mg
Number of subjects: 14
Study 32644127 — intervention group
Group type: COMPARATOR
Intervention: KAF156 20 mg
Number of subjects: 14
Study 32644127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 32989714 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic skepticism (GSI)
Number of subjects: 862
Study 32989714 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic OCPs
Number of subjects: 862
Study 32989714 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic drugs
Number of subjects: 862
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) at doses of 25, 100, 200, 400, and 800 µg/day
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) at doses of 50, 200, 500, 1000, and 2000 µg/day
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) at doses of 100, 400, 800, 1600, and 3200 µg/day
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) at therapeutic doses
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) at therapeutic doses
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) at therapeutic doses
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) at highest/supratherapeutic doses
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) at highest/supratherapeutic doses
Number of subjects: 54
Study 35900313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) at comparable therapeutic doses (100 µg/day)
Number of subjects: 54
Study 32816877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0
Study 36054180 — intervention group
Group type: EXPERIMENTAL
Intervention: High intrinsic renal sodium avidity (IRSA)
Number of subjects: 339
Study 36054180 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental loop diuretic dose titration after >24 h
Number of subjects: 339
Study 36054180 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intrinsic renal sodium avidity (IRSA)
Number of subjects: 339
Study 33658762 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol palmitate ophthalmic solution
Number of subjects: 0